Pitt Innovators Deliver Robust Year of Impact in Fiscal 2026
Fiscal Year 2026 marked a year of remarkable progress across the University of Pittsburgh’s... Read more
VirTech Bio develops innovative therapies for organ and tissue preservation, ex vivo organ management and biomarker discovery using a technology platform combining machine perfusion (MP) with a new hemoglobin-based oxygen carrier (HBOC).